Showing results (101-110 of 190) with videos related to
Sort By:
Pageof 19
Medical Physics|October 6, 2014
ADC texture--an imaging biomarker for high-grade glioma?Patrik Brynolfsson, David Nilsson, Roger Henriksson, et al.Journal of Cancer Research and Clinical Oncology|September 1, 2015
Impact of functional germline variants and a deletion polymorphism in APOBEC3A and APOBEC3B on breast cancer risk and survival in a Swedish study populationStella Göhler, Miguel Inacio Da Silva Filho, Robert Johansson, et al.Acta Oncologica (Stockholm, Sweden)|March 25, 2021
Fertility-related information received by young women and men with cancer - a population-based surveyAlexandra Wide, Lena Wettergren, Johan Ahlgren, et al.Breast Cancer Research : BCR|September 20, 2005
Increased copy number at 3p14 in breast cancerIngrid Ljuslinder, Beatrice Malmer, Irina Golovleva, et al.European Journal of Haematology|July 19, 2008
Significant cytotoxic activity in vitro of the EGFR tyrosine kinase inhibitor gefitinib in acute myeloblastic leukaemiaElin Lindhagen, Anna Eriksson, Malin Wickström, et al.Neuro-Oncology|January 27, 2016
Bevacizumab, temozolomide, and radiotherapy for newly diagnosed glioblastoma: comprehensive safety results during and after first-line therapyFrank Saran, Olivier L Chinot, Roger Henriksson, et al.Neuro-Oncology|March 24, 2016
Upfront bevacizumab may extend survival for glioblastoma patients who do not receive second-line therapy: an exploratory analysis of AVAglioOlivier L Chinot, Ryo Nishikawa, Warren Mason, et al.Neuro-Oncology|August 13, 2016
Evaluation of pseudoprogression rates and tumor progression patterns in a phase III trial of bevacizumab plus radiotherapy/temozolomide for newly diagnosed glioblastomaWolfgang Wick, Olivier L Chinot, Martin Bendszus, et al.Cancer Medicine|March 27, 2021
Impact of meningioma surgery on use of antiepileptic, antidepressant, and sedative drugs: A Swedish nationwide matched cohort studyErik Thurin, Isabelle Rydén, Thomas Skoglund, et al.Neuro-Oncology|March 4, 2010
Genetic variations in EGF and EGFR and glioblastoma outcomeSara Sjöström, Ulrika Andersson, Yanhong Liu, et al.Pageof 19